March 02, 2023
U.S. and China Can Show World Leadership by Safeguarding Military AI
The recent balloon incident highlights the fragility of US-China relations and the risk of accidents and miscalculation. While balloons are a 200-year-old technology, the United States and China are developing new technologies that come with new risks. Chief among these is artificial intelligence (AI), which has many military applications but also can lead to accidents or humans overtrusting in machines.
The US and China must move beyond unilateral statements and begin developing shared confidence-building measures to manage the risks of military AI competition.
The hasty deployment by Microsoft and Google of chatbots like ChatGPT demonstrates the risks of moving too quickly with an unproven technology. Competitive pressures in the private sector have led tech companies to race ahead to field AI systems that are not safe. Nations must avoid similar temptations with military AI.
Read the full article from South China Morning Post.
More from CNAS
-
Biotech Matters: Public-Private Coordination of Biotechnology
Reports
An appreciation of biotechnology’s great opportunities is, for many commentators, intimately joined with regret about a disconnect between the U.S. government and the private ...
By Richard Danzig
-
$6.6 billion TSMC deal in Arizona the latest in the CHIPS Act’s rollout
Podcast
“President Biden signed the CHIPS and Science Act just about 20 months ago, which in government time is yesterday. And they’ve hired 200 people,” said Vivek Chilukuri, a senio...
By Vivek Chilukuri
-
Response to NTIA Request for Comment: “Dual Use Foundation Artificial Intelligence Models with Widely Available Model Weights”
Commentary
In February 2024, the Department of Commerce’s National Telecommunications and Information Administration (NTIA) issued a Request for Comment (RFC) on the implications of “ope...
By Caleb Withers
-
Biotech Matters: Great Data Competition and Interoperability with Allies and Partners
Reports
Understanding and strengthening America’s biotechnology leadership requires exploring the limits of existing data relevant to the U.S. bioeconomy so that policymakers and the ...
By Michelle Holko
